TTK Healthcare Announces FY26 Results, Recommends Rs. 10 Dividend; Nods Appointment of Cost Auditor
TTK Healthcare Limited announced the approval of its audited financial results for the fourth quarter and the full year ended March 31, 2026. The Board of Directors also recommended a dividend of Rs. 10 per equity share for the fiscal year.The company held its Board of Directors meeting on May 30, 2026, where it approved the audited financial results for the quarter and year. The audited report was issued by the Statutory Auditors, M/s PKF Sridhar & Santhanam LLP, Chartered Accountants, confirming an unmodified opinion.
Governance and Board Actions
During the board meeting, the company approved the reappointment of Mr. T T Raghunathan as Executive Chairman and Whole-time Director for a further term of 5 years, effective from November 01, 2026.Furthermore, the company approved the appointment of M/s Geeyes & Co. as the Cost Auditor for the financial year 2026-27.
TTK Healthcare also set the date for the 68th Annual General Meeting (AGM) as Friday, July 24, 2026, to be held through Video Conferencing / Other Audio Visual Means (VC / OAVM).
Financial Highlights for FY 2026-27
The company reported robust performance across its segments for the year ended March 31, 2026. The Board recommended a dividend of Rs. 10/- (100%) per Equity Share of Rs. 10/- each for the financial year ended March 31, 2026, subject to the approval of the shareholders at the ensuing AGM.The financial performance summary for the year is as follows:
| Metric | FY 2026-27 | FY 2025-26 |
|---|---|---|
| Total Income | 92,943.11 | 87,274.83 |
| Profit after Tax | 6,568.05 | 8,165.69 |
| Total Comprehensive Income | 7,825.96 | 6,393.25 |
The revenue generation was highest in the Protective Devices segment, which reported a Total Income from Operations of Rs. 21,650.81 lakhs for the year.
Segment results for the full year ended March 31, 2026, totaled Rs. 8,256.30 lakhs before tax, compared to Rs. 10,833.18 lakhs in the previous year.
| Segment | Total Income from Operations (Lakhs) | Net Profit / (Loss) (Lakhs) |
|---|---|---|
| Protective Devices | 21,650.81 | 252.62 |
| Consumer Products | 24,127.82 | 2,345.32 |
| Medical Devices | 10,691.69 | 2,215.05 |
| Foods | 15,109.96 | 449.89 |
| Animal Welfare | 14,108.37 | 1,098.52 |
| Others | 39.46 | 14.70 |
Key Financial Considerations
The company noted that its profit for the period before tax (after exceptional and/or extraordinary items) was Rs. 8,256.30 lakhs, while the profit after tax stood at Rs. 6,568.05 lakhs.The company provided specific details regarding exceptional items recognized in the Statement of Profit and Loss for the year ended March 31, 2026:
- Labor Codes Impact: The incremental impact arising from the change in the definition of wages was recognized as Exceptional Items. This comprised Gratuity of Rs. 823.02 lakhs and Long-term Compensated Absences of Rs. 284.85 lakhs. After adjusting for a provision of Rs. 350 lakhs created in FY 2020-21, the net charge recognized in the third quarter was Rs. 757.87 lakhs.
- Previous Year Exceptional Items:
* In the fourth quarter of the previous year, the company wrote off Male Contraceptives for the Protective Devices Division, amounting to Rs. 586.39 lakhs.
Balance Sheet and Cash Flow Summary
As of March 31, 2026, the company's total assets amounted to Rs. 1,32,874.25 lakhs. The total equity and liabilities stood at the same figure.The Statement of Cash Flow showed that the company generated Rs. 12,111.82 lakhs from operating activities, resulting in a strong overall cash flow.
| Cash Flow Component | FY 2026-27 (Audited) | FY 2025-26 (Audited) |
|---|---|---|
| Cash Generated from Operating Activities | 12,111.82 lakhs | 2,383.41 lakhs |
| Cash Flow from Investing Activities | 5,157.91 lakhs | 2,206.65 lakhs |
| Cash Flow from Financing Activities | (1,755.59) lakhs | (1,808.06) lakhs |
| Net Increase / (Decrease) in Cash | 1,287.50 lakhs | (195.xx) lakhs |
| Cash and Cash Equivalents at Year End | 1,352.50 lakhs | 1,004 lakhs |
The Board of Directors reaffirmed the company's continued monitoring of developments related to Labour Codes and stated that it is in the process of revising its Wage Structure in FY 2026-27.
The full audited financial results are available on the respective stock exchange and company websites.
TTKHLTCARE Stock Price Movement
On Friday, shares of TTK Healthcare Limited slipped by 0.68% to close at ₹891.85. The stock saw a total traded volume of 2,209 shares, marking its downward trend in the pharmaceutical sector.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.
Last edited by a moderator: